The Genetics and Epigenetics Program focuses on the fundamental genetic, epigenetic, and genomic mechanisms underlying cancer development, progression, and treatment, with the aim of translating basic research discoveries and new technologies into clinical application. The goals of this program are to align and synergize research within the team, facilitate collaborations between basic research and clinical groups, build genetic and epigenetic platforms and resources, and prepare the team for internal and external grant applications.
Scientist, Senior Scientist, Clinician Scientist
Lupien, Mathieu
(chair)
Bratman, Scott
Cescon, David
De Carvalho, Daniel
He, Housheng (Hansen)
Kim, Raymond
Kridel, Robert
Nguyen, Long
Notta, Faiyaz
Oza, Amit
Penn, Linda
Shepherd, Frances
Siu, Lillian
Stewart, Keith
Tsao, Ming-Sound
Zadeh, Gelareh
Assistant Scientist
Bunda, Severa
Affiliate Scientist
Chen, Eric (Xueyu)
Li, Bowen
Moghal, Nadeem
Affiliate Scientist
Zeng, Yong
Staff Scientist
Ketela, Troy
Orouji, Elias
Clinical Champion
Berman, Hal
Fleshner, Neil
Gallinger, Steven
van der Kwast, Theo